Outcome of Idiopathic Macular Hole

This study has been completed.
Sponsor:
Information provided by:
Centre Hospitalier Universitaire Dijon
ClinicalTrials.gov Identifier:
NCT00941291
First received: March 30, 2009
Last updated: July 16, 2009
Last verified: July 2009

March 30, 2009
July 16, 2009
January 2002
Not Provided
Long-term outcome of idiopathic macular hole surgery [ Time Frame: 37 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00941291 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Outcome of Idiopathic Macular Hole
Long-term Outcome of Idiopathic Macular Hole Surgery

The purpose of this study is to evaluate the role of cataract surgery and cystoid macular edema (CME) on reopening of idiopathic macular holes (IMH).

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample

One hundred and thirty patients (135 eyes) with stage 2, 3, or 4 IMH were included after successful IMH repair

Idiopathic Macular Hole
Not Provided
  • vitrectomy in pseudophakic eyes
  • vitrectomy and cataract:combined procedure
  • vitrectomy followed by cataract extraction
  • vitrectomy on phakic eyes
Passemard M, Yakoubi Y, Muselier A, Hubert I, Guillaubey A, Bron AM, Berrod JP, Creuzot-Garcher C. Long-term outcome of idiopathic macular hole surgery. Am J Ophthalmol. 2010 Jan;149(1):120-6. Epub 2009 Oct 20.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
135
January 2005
Not Provided

Inclusion Criteria:

  • Patients with with stage 2, 3, or 4 Idiopathic Macular Hole after successful Idiopathic Macular Hole repair

Exclusion Criteria:

  • All patients without stage 2, 3, or 4 Idiopathic Macular Hole repair
Both
18 Years to 90 Years
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT00941291
Macular hole 1
No
Professor Creuzot-Garcher Catherine
Centre Hospitalier Universitaire Dijon
Not Provided
Principal Investigator: Catherine Creuzot-Gracher, MD, PhD Ophthalmology unit CHU Dijon
Centre Hospitalier Universitaire Dijon
July 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP